Welcome to our dedicated page for Senestech news (Ticker: SNES), a resource for investors and traders seeking the latest updates and insights on Senestech stock.
SenesTech, Inc. develops and commercializes fertility-control products for managing animal pest populations, with current products focused on rat and mouse populations. Its product names include ContraPest, Evolve Rat, and Evolve Mouse, which are used within pest-management programs as alternatives or complements to traditional rodent-control methods.
Company news centers on Evolve commercialization, e-commerce and direct-to-consumer sales channels, Amazon marketplace management, field-study data on rodent activity, product approvals in international markets, quarterly and annual financial results, capital runway commentary, and executive leadership or board governance updates.
SenesTech (Nasdaq: SNES), a leader in fertility control for managing animal pest populations, announced the deployment of its Evolve™ fertility control solution in the U.S. Virgin Islands. This initiative, part of an international effort to control invasive species in environmentally sensitive regions, is administered by the Wild Ecology Group. Evolve™ will be used across over 60 islands and has been identified as a long-term, sustainable solution to invasive species proliferation. The initial multi-pallet order is already en route to the Virgin Islands, with regular orders scheduled. Evolve™ effectively addresses rodent overpopulation by reducing fertility rather than using poisons. The product is easy to deploy and suitable for various environments.
SenesTech has announced its participation in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024. CEO Joel Fruendt and CFO Tom Chesterman will present a webcast at 11:45am ET and host one-on-one meetings with investors. The webcast can be accessed via the conference home page or directly through a provided link, with a replay available post-event. Investors can schedule one-on-one meetings by contacting Lytham Partners or registering on the event's website.
SenesTech has launched its Evolve™ fertility control solution for rats on Amazon. Evolve, a minimum risk soft bait, aims to address rodent overpopulation by reducing fertility rather than using poisons. Previously available only to professionals, Evolve is now accessible to everyday consumers, aiming to revolutionize pest control. The product contains an active ingredient proven to reduce rodent fertility in independent studies. Currently, the U.S. rodent pest management market is valued over $1 billion annually, with significant growth in e-commerce sales. Increasing regulatory restrictions on traditional poisons further highlight the potential for Evolve's market expansion.
SenesTech, Inc. announced record quarterly revenues of $415,000 in Q1 2024, a 78% increase compared to Q1 2023. Their product Evolve™ is the biggest-selling product, contributing over 50% of revenue. The company secured distribution agreements, expanded its geographic reach, and introduced new products like Evolve Mouse. The financial results showed a net loss of $1.8 million, with an Adjusted EBITDA loss of $1.7 million. Cash at the end of March 2024 was $3.6 million. The management is optimistic about the commercial and development milestones achieved in 2024, including the launch of a dedicated Amazon store and expansion of the addressable market with Evolve Mouse.
SenesTech, Inc. (NASDAQ: SNES) will report financial results for its first quarter of 2024 on May 9, 2024, following the market close. A conference call is scheduled for the same day at 5:00 pm ET to discuss the results.
SenesTech, Inc. has launched Evolve™ Mouse, a revolutionary soft bait to control mouse populations, designated as a 'minimum risk' product by the U.S. Environmental Protection Agency. The product offers an effective and convenient solution for consumers and professionals, aiming to address the growing rodent pest management market.
Summary not available.
Summary not available.
Summary not available.
Summary not available.